Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer

  • Peeters M
  • Price T
  • Cervantes A
 et al. 
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.

Author-supplied keywords

  • antibody
  • chemotherapy
  • folfiri
  • metastatic colorectal cancer
  • panitumumab

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • M Peeters

  • T J Price

  • A Cervantes

  • A F Sobrero

  • M Ducreux

  • Y Hotko

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free